Stocktoria

Cell Source, Inc. CLCS

OTC · stock · Pharmaceutical Preparations · website · IPO 2014-01-14

Cell Source, Inc. statistics & valuation

Market cap$52.8M

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2015201620172018201920202021202220232024
Operating margin (%)
2015201620172018201920202021202220232024
Return on equity (%)
2015201620172018201920202021202220232024
Shares outstanding
23.9M 24.7M 25.3M 26.1M 27.1M 32.5M 34.4M 36.1M 39.8M 45.0M 2015201620172018201920202021202220232024
Net debt ($)
-$321048 2015201620172018201920202021202220232024
Share buybacks ($)
2015201620172018201920202021202220232024
Return on assets (%)
-1165.60% -458.40% -579.80% -3218.40% -3899.10% -1008.10% -1744.10% -1260.90% -2726.40% -1575.10% 2015201620172018201920202021202220232024
Free cash flow margin (%)
2015201620172018201920202021202220232024
Debt / equity (×)
2015201620172018201920202021202220232024
EPS ($)
-$0.19 -$0.18 -$0.17 -$0.14 2015201620172018201920202021202220232024

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Return on assets-1575.1%-2726.4%-1260.9%-1744.1%-1008.1%-3899.1%-3218.4%-579.8%-458.4%-1165.6%
Return on equity24.3%34.1%40.9%55.7%57.4%77.9%43.0%67.6%15.5%43.5%
Debt / equity———————-0.01×——
Current ratio———0.030.05——0.100.030.04

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.